Biobot Surgical builds robotic-assisted platforms for precise prostate biopsies and ablations using MRI-ultrasound fusion guidance.
$15.6MSeries B
A $15.6M Series B for a precision robotics play in urology signals that MRI-guided interventions are moving from research into reimbursable procedures—this is about de-risking the clinical pathway, not just building cooler hardware. If you're in adjacent image-guided surgery spaces (cardiac, orthopedic), watch whether Biobot's fusion approach becomes a standard-of-care requirement that forces your own roadmap.